Leif Bjermer
31 – 40 of 362
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy
(
- Contribution to journal › Article
-
Mark
Allergen provocation tests in respiratory research : building on 50 years of experience
(
- Contribution to journal › Article
-
Mark
Histology-based blood leukocyte profiling reveals parallel Th2 and Th17 signatures in seasonal allergic rhinitis
(
- Contribution to journal › Article
-
Mark
Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD
(
- Contribution to journal › Scientific review
-
Mark
Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics
(
- Contribution to journal › Article
- 2021
-
Mark
Human Primary Airway Basal Cells Display a Continuum of Molecular Phases from Health to Disease in Chronic Obstructive Pulmonary Disease
(
- Contribution to journal › Article
-
Mark
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening : a post hoc analysis of the EMAX trial
(
- Contribution to journal › Article
-
Mark
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD : A Prespecified Analysis of The EMAX Trial
(
- Contribution to journal › Article
-
Mark
ERS/EAACI statement on adherence to international adult asthma guidelines
(
- Contribution to journal › Scientific review
-
Mark
A new protocol for exercise testing in COPD; improved prediction algorithm for WMAX and validation of the endurance test in a placebo-controlled double bronchodilator study
(
- Contribution to journal › Article